A new trial suggests the optimal approach for basilar artery occlusion stroke may vary depending on whether the blockage ...

ATLANTA, (Oct. 27, 2025) – Northwestern Senior Dianna Lee fired a 2-under-par 34 to claim women’s medalist honors at the 11 ...

Tenecteplase improved functional outcomes without added safety risk in selected basilar artery occlusion stroke treated up to 24 hours after onset in the TRACE-5 trial.

Any aspirin use linked to lower hazards of MI, ischemic stroke, with greater benefit in high-frequency use group ...

"Our findings highlight the interconnectedness of heart and vascular health with brain health in middle-aged and older adults ...

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes ...

Objectives To evaluate the long-term efficacy of remote ischaemic postconditioning (RIPC) on functional outcomes in patients ...

The FDA has approved Rybelsus® to reduce the risk of MACE in adults with T2DM who are at high risk for these events.

CLEVELAND — More than 795,000 Americans experience a stroke each year, with nearly half of survivors living with physical disabilities. For decades, rehabilitation has been the only option for ...

The approval was based on the SOUL trial, which evaluated oral semaglutide in adults 50 years and older with T2DM and ...

In the recent SOUL trial, the GLP-1 drug reduced the risk of MACE by 14% over 4 years. Next up: a possible obesity indication.

However, star cornerback Patrick Surtain II left the latter contest early due to injury on Sunday. The 2024 NFL Defensive ...